Table 2 Visual and Refractive Outcomes.
Total (n = 65) | Flange group (n = 31) | Suture group (n = 34) | P | |
|---|---|---|---|---|
Preoperative | ||||
UCVA (logMAR) | 1.292 ± 0.697 | 1.248 ± 0.672 | 1.331 ± 0.727 | 0.637* |
BCVA (logMAR) | 0.320 ± 0.402 | 0.266 ± 0.239 | 0.369 ± 0.506 | 0.307* |
Spherical equivalent (D) | 6.72 ± 5.53 | 7.24 ± 5.37 | 6.24 ± 5.72 | 0.472* |
Refractive astigmatism (D) | − 0.61 ± 0.96 | − 0.46 ± 0.80 | − 0.74 ± 1.07 | 0.236* |
Postoperative, 1 month | ||||
UCVA (logMAR) | 0.484 ± 0.355 | 0.425 ± 0.346 | 0.538 ± 0.360 | 0.203* |
BCVA (logMAR) | 0.297 ± 0.296 | 0.276 ± 0.299 | 0.316 ± 0.297 | 0.596* |
Spherical equivalent (D) | − 1.03 ± 1.09 | − 0.71 ± 0.94 | − 1.33 ± 1.15 | 0.019* |
Refractive astigmatism (D) | − 1.32 ± 1.00 | − 1.14 ± 0.79 | − 1.48 ± 1.16 | 0.175* |
Postoperative, 2 month | ||||
UCVA (logMAR) | 0.342 ± 0.285 | 0.266 ± 0.244 | 0.411 ± 0.305 | 0.048† |
BCVA (logMAR) | 0.196 ± 0.225 | 0.158 ± 0.193 | 0.231 ± 0.249 | 0.194* |
Spherical equivalent (D) | − 1.06 ± 1.08 | − 0.73 ± 0.92 | − 1.36 ± 1.15 | 0.018* |
Refractive astigmatism (D) | − 1.30 ± 0.94 | − 1.20 ± 0.79 | − 1.38 ± 1.05 | 0.441* |
Postoperative, 6 month | ||||
UCVA (logMAR) | 0.327 ± 0.334 | 0.251 ± 0.328 | 0.418 ± 0.339 | 0.041* |
BCVA (logMAR) | 0.149 ± 0.203 | 0.125 ± 0.213 | 0.171 ± 0.195 | 0.367* |
Spherical equivalent (D) | − 1.11 ± 1.07 | − 0.74 ± 0.93 | − 1.44 ± 1.09 | 0.007* |
Refractive astigmatism (D) | − 1.30 ± 0.93 | − 1.18 ± 0.73 | − 1.41 ± 1.09 | 0.316* |